Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $3.31 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.